19:23 31/10/2014 Will Arena Pharma (ARNA) Q3 Loss Be Wider than Expected?
Will Arena Pharma (ARNA) Q3 Loss Be Wider than Expected?
Zacks.com - 3 hours ago
Arena Pharmaceuticals, Inc. (ARNA - Snapshot Report) is scheduled to report its third-quarter 2014 results before the opening bell on Nov 3. Last quarter, the company had posted a negative earnings surprise of 9.09%.

16:07 31/10/2014 Arena Pharmaceuticals (ARNA) to Release Quarterly Earnings on Monday
Arena Pharmaceuticals (ARNA) to Release Quarterly Earnings on Monday
WKRB News - 6 hours ago
Arena Pharmaceuticals logo Arena Pharmaceuticals (NASDAQ:ARNA) is scheduled to issue its Q314 quarterly earnings data on Monday, November 3rd.

13:22 31/10/2014 Arena Pharmaceuticals Inc (NASDAQ:ARNA) Weekly Performance Is Improving
Arena Pharmaceuticals Inc (NASDAQ:ARNA) Weekly Performance Is Improving
WallStreet Scope - 9 hours ago
Arena Pharmaceuticals Inc (NASDAQ:ARNA) has a one year low of $3.26 and a one year high of $7.97. Arena Pharmaceuticals Inc (NASDAQ:ARNA) opened with a price of 4.26 and hit a high of 4.46 with a low of 4.15 on the last trading day.. Arena ...

11:37 31/10/2014 Watch List -Nanosphere, Inc. (NSPH), Arena Pharmaceuticals, Inc. (NASDAQ ...
Watch List -Nanosphere, Inc. (NSPH), Arena Pharmaceuticals, Inc. (NASDAQ ...
Techsonian (press release) - 11 hours ago
Houston, TX - Oct31, 2014 - (Techsonian) –Nanosphere, Inc. (NASDAQ:NSPH)declared that it will inform its results for the third quarter of 2014 on Wednesday, November 5, 2014.

20:26 30/10/2014 Arena Pharmaceuticals's Market Perform Rating Reiterated at BMO Capital ...
Arena Pharmaceuticals's Market Perform Rating Reiterated at BMO Capital ...
sleekmoney - Oct 30, 2014
Arena Pharmaceuticals, Inc. logo BMO Capital Markets reiterated their market perform rating on shares of Arena Pharmaceuticals (NASDAQ:ARNA) in a research note released on Thursday morning.
Arena Pharmaceuticals Receives "Market Perform" Rating from BMO Capital ... - Mideast Time
News Recap: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Achillion ... - Market News Call

15:00 29/10/2014 Trader's Buzz: Unilife Corporation (UNIS), Arena Pharmaceuticals (ARNA ...
Trader's Buzz: Unilife Corporation (UNIS), Arena Pharmaceuticals (ARNA ...
Wall Street Pit - Oct 29, 2014
ARNA shares recently gained $0.01 to $4.36. The stock is down more than 2.22% year-over-year and has lost roughly 24.79% year-to-date.

13:20 22/10/2014 Could Arena Pharmaceuticals Inc. Be Running Out of Money?
Could Arena Pharmaceuticals Inc. Be Running Out of Money?
Motley Fool - Oct 22, 2014
One biotech in particular that investors should be watching the cash burn rate of very closely is Arena Pharmaceuticals (NASDAQ: ARNA ) . With Wall Street not expecting the company to be profitable on annual basis until 2017, it's worth digging beyond ...

14:31 17/10/2014 Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA ...
Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA ...
PR Newswire (press release) - Oct 17, 2014
Investor-Edge has initiated coverage on the following equities: Arena Pharmaceuticals Inc. (NASDAQ: ARNA), NPS Pharmaceuticals Inc. (NASDAQ: NPSP), XOMA Corporation (NASDAQ: XOMA), Momenta Pharmaceuticals Inc. (NASDAQ: MNTA), and ...

15:43 13/10/2014 Pharma Stocks to Watch: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA ...
Pharma Stocks to Watch: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA ...
Street Newswire (registration) - Oct 13, 2014
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Monday said data from phase 3 clinical trials of its obesity drug BELVIQ (lorcaserin HCl) will be presented at the American College of Clinical Pharmacy meeting taking place through Wednesday of this week.